Results 161 to 170 of about 249,886 (308)
ABSTRACT Accumulating evidence suggests that the intestinal microbiota participates in the progression of metabolic dysfunction‐associated steatotic liver disease (MASLD) through microbiota‐host interaction. However, the beneficial role of commensal mycobiota in MASLD progression remains poorly understood.
Shuping Qiao +11 more
wiley +1 more source
Trends in immunomodulatory therapy for the treatment of chronic uveitis in the United States. [PDF]
Zhang C +4 more
europepmc +1 more source
Application of immunomodulatory therapy in a human brucellosis patient with pancytopenia: A case report. [PDF]
Wu L +5 more
europepmc +1 more source
This study established an RT‐MSCs‐based therapeutic approach for scleroderma in mice. RT‐MSCs attenuated fibrosis by regulating mitochondrial autophagy and restored gut microbiota homeostasis. Metabolomic analyses confirmed recovery of key metabolites, and RT‐MSCs demonstrated favorable lesion targeting and safety profiles.
Xue Xia +5 more
wiley +1 more source
Case Report: PET/CT assessment of immunomodulatory therapy in anti-IgLON5 encephalitis with sleep apnea. [PDF]
Liu Y +7 more
europepmc +1 more source
Potential targets of phytochemical immunomodulatory therapy in periodontitis immunopathogenesis: A narrative review. [PDF]
Sarasati A, Jonarta AL.
europepmc +1 more source
A real‐world model of structured animal product restriction practiced for religious reasons reveals the dynamic adaptability of the human gut microbiome to dietary change and uncovers reductions in diversity and rare taxa loss. Integrated microbiome, metabolomic, and proteomic analyses uncover coordinated taxonomic and molecular shifts and identify ...
Christina Emmanouil +7 more
wiley +1 more source
Man Yu,1,* Xingying Chen,2,* Fanlin Meng,1 Shue Tian3 1Department of Dermatology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610072, People’s Republic of China; 2Department of Dermatology, Yuebei ...
Yu M, Chen X, Meng F, Tian S
doaj
The Many Faces of NLRs in Macrophage Biology∗
Nikolaos G. Frangogiannis, MD
doaj +1 more source

